NCT00633750 2012-09-05
Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery
Vanderbilt-Ingram Cancer Center
Phase 2 Completed
Clinical Trials
1 trialsPhase 2 × Breast Neoplasms × Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization × Clear all